UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

American Society of Clinical Oncology Statement: Biosimilars in Oncology

Journal of clinical oncology, 2018-04, Vol.36 (12), p.1260-1265

2018

Volltextzugriff (PDF)

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1525-1530

2011

Volltextzugriff (PDF)

Telehealth in Oncology: ASCO Standards and Practice Recommendations

JCO oncology practice, 2021-09, Vol.17 (9), p.546-564

2021

Volltextzugriff (PDF)

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3199-3202

2010

Volltextzugriff (PDF)

Safe Handling of Hazardous Drugs: ASCO Standards

Journal of clinical oncology, 2019-03, Vol.37 (7), p.598-609

2019

Volltextzugriff (PDF)

N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer

Breast cancer research and treatment, 2020-08, Vol.182 (3), p.613-622

2020

Volltextzugriff (PDF)

American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment

Journal of clinical oncology, 2009-02, Vol.27 (6), p.986-993

2009

Volltextzugriff (PDF)

Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3146-3153

2010

Volltextzugriff (PDF)

Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1502-1516

2009

Volltextzugriff (PDF)

Reforming the community research program: from Community Clinical Oncology Program to the National Cancer Institute Community Oncology Research Program

American Society of Clinical Oncology educational book, 2014 (34), p.e116-e119

Zon, Robin T

2014

Volltextzugriff (PDF)

American Society of Clinical Oncology Statement on Minimum Standards and Exemplary Attributes of Clinical Trial Sites

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2562-2567

2008

Volltextzugriff (PDF)

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)

The Journal of supportive oncology, 2011-01, Vol.9 (1), p.24-31

2011

Volltextzugriff (PDF)

Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis

Clinical cancer research, 2006-10, Vol.12 (20), p.6094-6099

2006

Volltextzugriff (PDF)

Rationale, Opportunities, and Reality of Biosimilar Medications

The New England journal of medicine, 2018-05, Vol.378 (21), p.2036-2044

2018

Volltextzugriff (PDF)

American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology

Journal of oncology practice, 2016-03, Vol.12 (3), p.261

2016

Volltextzugriff (PDF)

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

Investigational new drugs, 2009-12, Vol.27 (6), p.565-570

2009

Volltextzugriff (PDF)

USP 3 : United in Safeguarding Patients, Personnel, and Providers

Journal of oncology practice, 2017-03, Vol.13 (3), p.145

Zon, Robin T

2017

Volltextzugriff (PDF)

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Journal of clinical oncology, 2021-01, Vol.39 (2), p.155-169

2021

Volltextzugriff (PDF)

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA

The Journal of supportive oncology, 2011-05, Vol.9 (3), p.105-112

2011

Volltextzugriff (PDF)

Safe Handling of Hazardous Drugs: ASCO Standards Summary

Journal of oncology practice, 2019-02, Vol.15 (2), p.112

2019

Volltextzugriff (PDF)

Deconstructing MACRA: the switch from volume- to value-based payment

The Journal of community and supportive oncology, 2016-09, Vol.14 (9), p.394-401

2016

Volltextzugriff (PDF)

National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22–24, 2009

JNCI : Journal of the National Cancer Institute, 2010-02, Vol.102 (3), p.161-169

2010

Volltextzugriff (PDF)

Abstract P2-14-11: Treatment recommendations in ER+ patients ≤ 50 years: Comparison of the 21-gene assay and 70-gene signature in the PROMIS study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-14-11

2020

Volltextzugriff (PDF)

Effect of Public Deliberation on Patient Attitudes Regarding Consent and Data Use in a Learning Health Care System for Oncology

Journal of clinical oncology, 2019-12, Vol.37 (34), p.3203-3211

2019

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Humans
(43)
Life Sciences & Biomedicine
(42)
Oncology
(37)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Middle Aged
(14)
Female
(13)
Tumors
(13)
Aged
(12)
Male
(11)
United States
(11)
Adult
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Chemotherapy
(7)
Neoplasms - Therapy
(7)
Treatment Outcome
(7)
Risk Factors
(6)
Antineoplastic Agents
(5)
Breast Neoplasms - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

American Society of Clinical Oncology Statement: Biosimilars in Oncology

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

Telehealth in Oncology: ASCO Standards and Practice Recommendations

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

Safe Handling of Hazardous Drugs: ASCO Standards

N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer

American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment

Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians

Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

Reforming the community research program: from Community Clinical Oncology Program to the National Cancer Institute Community Oncology Research Program

American Society of Clinical Oncology Statement on Minimum Standards and Exemplary Attributes of Clinical Trial Sites

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)

Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis

Rationale, Opportunities, and Reality of Biosimilar Medications

American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

USP 3 : United in Safeguarding Patients, Personnel, and Providers

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA

Safe Handling of Hazardous Drugs: ASCO Standards Summary

Deconstructing MACRA: the switch from volume- to value-based payment

National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22–24, 2009

Abstract P2-14-11: Treatment recommendations in ER+ patients ≤ 50 years: Comparison of the 21-gene assay and 70-gene signature in the PROMIS study

Effect of Public Deliberation on Patient Attitudes Regarding Consent and Data Use in a Learning Health Care System for Oncology

Suchergebnisse filtern